FDA NDC Directory · JSON-LD · Markdown

Etodolac

NDC 51672-4052 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerTaro Pharmaceuticals U.S.A., Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA076174
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsETODOLAC (500 mg/1)
Marketing started20030313
Package count6

External sources

Source: openFDA. Public-domain (CC0).